Minamimoto R - Search Results

1

Prospective Evaluation of ⁶⁸Ga-RM2 PET/MRI in Patients with Biochemical Recurrence of Prostate Cancer and Negative Findings on Conventional Imaging.

Minamimoto R, Sonni I, Hancock S, Vasanawala S, Loening A, Gambhir SS, Iagaru A. Minamimoto R, et al. J Nucl Med. 2018 May;59(5):803-808. doi: 10.2967/jnumed.117.197624. Epub 2017 Oct 30. J Nucl Med. 2018. PMID: 29084827 Free article.

2

[No title available]

[No authors listed] [No authors listed] PMID: 38214814

3

[Performance profile of FDG-PET and PET/CT for cancer screening based on a Japanese nationwide survey].

Minamimoto R, Senda M, Uno K, Jinnouchi S, Iinuma T, Ito K, Okuyama C, Oguchi K, Kawamoto M, Suzuki Y, Tsukamoto E, Terauchi T, Nakashima R, Nishio M, Nishizawa S, Fukuda H, Yoshida T, Inoue T. Minamimoto R, et al. Kaku Igaku. 2007 May;44(2):105-24. Kaku Igaku. 2007. PMID: 18240583 Japanese.

4

The potential of FDG-PET/CT for detecting prostate cancer in patients with an elevated serum PSA level.

Minamimoto R, Uemura H, Sano F, Terao H, Nagashima Y, Yamanaka S, Shizukuishi K, Tateishi U, Kubota Y, Inoue T. Minamimoto R, et al. Ann Nucl Med. 2011 Jan;25(1):21-7. doi: 10.1007/s12149-010-0424-4. Epub 2010 Oct 8. Ann Nucl Med. 2011. PMID: 20931305 Clinical Trial.

5

4'-[Methyl-11C]-thiothymidine PET/CT for proliferation imaging in non-small cell lung cancer.

Minamimoto R, Toyohara J, Seike A, Ito H, Endo H, Morooka M, Nakajima K, Mitsumoto T, Ito K, Okasaki M, Ishiwata K, Kubota K. Minamimoto R, et al. J Nucl Med. 2012 Feb;53(2):199-206. doi: 10.2967/jnumed.111.095539. Epub 2011 Dec 21. J Nucl Med. 2012. PMID: 22190643 Free article. Clinical Trial.

6

Amyloid imaging mismatch.

Minamimoto R, Ishii K, Kubota K, Morooka M, Okasaki M, Ito K, Mitsumoto T, Nakajima K, Sato T, Mochizuki M, Okazaki O. Minamimoto R, et al. Clin Nucl Med. 2012 Aug;37(8):807-9. doi: 10.1097/RLU.0b013e318251e1d3. Clin Nucl Med. 2012. PMID: 22785519

7

Simultaneous whole-body time-of-flight 18F-FDG PET/MRI: a pilot study comparing SUVmax with PET/CT and assessment of MR image quality.

Iagaru A, Mittra E, Minamimoto R, Jamali M, Levin C, Quon A, Gold G, Herfkens R, Vasanawala S, Gambhir SS, Zaharchuk G. Iagaru A, et al. Among authors: minamimoto r. Clin Nucl Med. 2015 Jan;40(1):1-8. doi: 10.1097/RLU.0000000000000611. Clin Nucl Med. 2015. PMID: 25489952 Free PMC article.

8

18F-sodium fluoride PET/CT in oncology: an atlas of SUVs.

Sabbah N, Jackson T, Mosci C, Jamali M, Minamimoto R, Quon A, Mittra ES, Iagaru A. Sabbah N, et al. Among authors: minamimoto r. Clin Nucl Med. 2015 Apr;40(4):e228-31. doi: 10.1097/RLU.0000000000000633. Clin Nucl Med. 2015. PMID: 25546225

9

Semiquantitative Analysis of the Biodistribution of the Combined ¹⁸F-NaF and ¹⁸F-FDG Administration for PET/CT Imaging.

Minamimoto R, Mosci C, Jamali M, Barkhodari A, Habte F, Jackson T, Mittra E, Gambhir SS, Iagaru A. Minamimoto R, et al. J Nucl Med. 2015 May;56(5):688-94. doi: 10.2967/jnumed.115.153767. Epub 2015 Apr 3. J Nucl Med. 2015. PMID: 25840978 Free article.

10

Biodistribution of the ¹⁸F-FPPRGD₂ PET radiopharmaceutical in cancer patients: an atlas of SUV measurements.

Minamimoto R, Jamali M, Barkhodari A, Mosci C, Mittra E, Shen B, Chin F, Gambhir SS, Iagaru A. Minamimoto R, et al. Eur J Nucl Med Mol Imaging. 2015 Nov;42(12):1850-8. doi: 10.1007/s00259-015-3096-4. Epub 2015 Jun 11. Eur J Nucl Med Mol Imaging. 2015. PMID: 26062933 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

161 results

Search Page

Filters